1 / 8

Private Placement Offering and/or Strategic Alliance Proposal

Private Placement Offering and/or Strategic Alliance Proposal. bioZhena Corporation. 10/28/2019. 1. Target Customers’ Profile. 30% Sub-fertile. 70% Birth control. 100% Cervical health cancer, STDs. Three statistics tell the story Personalized medicine - diagnostic tools.

tyler
Télécharger la présentation

Private Placement Offering and/or Strategic Alliance Proposal

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Private Placement Offeringand/orStrategic Alliance Proposal bioZhena Corporation 10/28/2019 bioZhena Corporation 1

  2. Target Customers’ Profile 30% Sub-fertile 70% Birth control 100% Cervical health cancer, STDs Three statistics tell the story Personalized medicine - diagnostic tools $232 Billion personalized medicine market to grow 11% annually said PricewaterhouseCoopers bioZhena Corporation

  3. 70% of women “would switch” 70% of women who would buy the Ovulona Smart Sensor, would switch from their current birth control to our fertility status monitor [from a survey of 5,000 US women] bioZhena Corporation

  4. Cervical Cancer/STD Screen Innocuous affordable triage for colposcopy-biopsy Billions women globally. Tens of millions reproductive-age women in the U.S. alone. This screen is for everyone. Affordable. Private. Solid. As the sensor monitors cervical tissues, other STDs will be detected. Sexually Transmitted Diseases bioZhena Corporation

  5. OtherProspectiveSolutions Menstrual Cycle Problems … Monitoring Pregnancy Cramps, PMS Instantly Detect Pregnancy Differential Diagnosis Prevent Prematurity Determine Right Time for procedures and medications Right Time for Meds Compute Delivery Day bioZhena Corporation

  6. Applications, apps Helping to Conceive & Monitor Pregnancy Managing Menstrual Cycle - Vital Sign Natural Birth Control Managing Menopause Cervical Cancer, STD Screening bioZhena Corporation

  7. Total Available Market Cervical cancer screening is an estimated annual $5B US Pap smear test market. Worldwide extrapolation: >$100B annually. Ovulona™ will save an est. 50% - 90%. Segments of bioZhena’s target market: Conceive & Monitor Pregnancy Market Managing Menstrual Cycle Market Birth Control Market Managing Menopause Market Cervical Health Screening Market U.S. ~$ 25B World >$500B 10/28/2019 bioZhena Corporation bioZhena Corporation 7

  8. bioZhena Corporation’s Offering Personalized Women’s Health Management bioZhena Corporation Contact vaclav@biozhena.com

More Related